117 related articles for article (PubMed ID: 10521440)
1. Kinetics of ternary complex formation with fusion proteins composed of the A(1)-adenosine receptor and G protein alpha-subunits.
Waldhoer M; Wise A; Milligan G; Freissmuth M; Nanoff C
J Biol Chem; 1999 Oct; 274(43):30571-9. PubMed ID: 10521440
[TBL] [Abstract][Full Text] [Related]
2. A galpha(s) carboxyl-terminal peptide prevents G(s) activation by the A(2A) adenosine receptor.
Mazzoni MR; Taddei S; Giusti L; Rovero P; Galoppini C; D'Ursi A; Albrizio S; Triolo A; Novellino E; Greco G; Lucacchini A; Hamm HE
Mol Pharmacol; 2000 Jul; 58(1):226-36. PubMed ID: 10860945
[TBL] [Abstract][Full Text] [Related]
3. Partial rescue of functional interactions of a nonpalmitoylated mutant of the G-protein G alpha s by fusion to the beta-adrenergic receptor.
Ugur O; Onaran HO; Jones TL
Biochemistry; 2003 Mar; 42(9):2607-15. PubMed ID: 12614155
[TBL] [Abstract][Full Text] [Related]
4. Activation of the beta(2)-adrenergic receptor-Galpha(s) complex leads to rapid depalmitoylation and inhibition of repalmitoylation of both the receptor and Galpha(s).
Loisel TP; Ansanay H; Adam L; Marullo S; Seifert R; Lagacé M; Bouvier M
J Biol Chem; 1999 Oct; 274(43):31014-9. PubMed ID: 10521499
[TBL] [Abstract][Full Text] [Related]
5. Selective stabilization of the high affinity binding conformation of glucagon receptor by the long splice variant of Galpha(s).
Unson CG; Wu CR; Sakmar TP; Merrifield RB
J Biol Chem; 2000 Jul; 275(28):21631-8. PubMed ID: 10791965
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins.
Wise A; Sheehan M; Rees S; Lee M; Milligan G
Biochemistry; 1999 Feb; 38(8):2272-8. PubMed ID: 10029519
[TBL] [Abstract][Full Text] [Related]
7. Control of the efficiency of agonist-induced information transfer and stability of the ternary complex containing the delta opioid receptor and the alpha subunit of G(i1) by mutation of a receptor/G protein contact interface.
Moon HE; Bahia DS; Cavalli A; Hoffmann M; Milligan G
Neuropharmacology; 2001 Sep; 41(3):321-30. PubMed ID: 11522323
[TBL] [Abstract][Full Text] [Related]
8. The human histamine H2-receptor couples more efficiently to Sf9 insect cell Gs-proteins than to insect cell Gq-proteins: limitations of Sf9 cells for the analysis of receptor/Gq-protein coupling.
Houston C; Wenzel-Seifert K; Bürckstümmer T; Seifert R
J Neurochem; 2002 Feb; 80(4):678-96. PubMed ID: 11841575
[TBL] [Abstract][Full Text] [Related]
9. Biased inhibition by a suramin analogue of A1-adenosine receptor/G protein coupling in fused receptor/G protein tandems: the A1-adenosine receptor is predominantly coupled to Goalpha in human brain.
Kudlacek O; Waldhoer M; Kassack MU; Nickel P; Salmi JI; Freissmuth M; Nanoff C
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):8-16. PubMed ID: 11862328
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the role of the carboxyl-terminal tails of the alpha and beta isoforms of the human thromboxane A(2) receptor (TP) in mediating receptor:effector coupling.
Walsh M; Foley JF; Kinsella BT
Biochim Biophys Acta; 2000 Apr; 1496(2-3):164-82. PubMed ID: 10771086
[TBL] [Abstract][Full Text] [Related]
11. The allosteric enhancer PD81,723 increases chimaeric A1/A2A adenosine receptor coupling with Gs.
Bhattacharya S; Youkey RL; Ghartey K; Leonard M; Linden J; Tucker AL
Biochem J; 2006 May; 396(1):139-46. PubMed ID: 16390330
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
[TBL] [Abstract][Full Text] [Related]
13. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of Galpha(z)-specific sequence at the carboxyl terminus increases the promiscuity of galpha(16) toward G(i)-coupled receptors.
Mody SM; Ho MK; Joshi SA; Wong YH
Mol Pharmacol; 2000 Jan; 57(1):13-23. PubMed ID: 10617674
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of receptor/G protein coupling by suramin analogues.
Beindl W; Mitterauer T; Hohenegger M; Ijzerman AP; Nanoff C; Freissmuth M
Mol Pharmacol; 1996 Aug; 50(2):415-23. PubMed ID: 8700151
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of beta(2)-adrenoceptor coupling to G(s)-, G(i)-, and G(q)-proteins.
Wenzel-Seifert K; Seifert R
Mol Pharmacol; 2000 Nov; 58(5):954-66. PubMed ID: 11040042
[TBL] [Abstract][Full Text] [Related]
17. Gating properties of GIRK channels activated by Galpha(o)- and Galpha(i)-coupled muscarinic m2 receptors in Xenopus oocytes: the role of receptor precoupling in RGS modulation.
Zhang Q; Pacheco MA; Doupnik CA
J Physiol; 2002 Dec; 545(2):355-73. PubMed ID: 12456817
[TBL] [Abstract][Full Text] [Related]
18. Gbetagamma-activated inwardly rectifying K(+) (GIRK) channel activation kinetics via Galphai and Galphao-coupled receptors are determined by Galpha-specific interdomain interactions that affect GDP release rates.
Zhang Q; Dickson A; Doupnik CA
J Biol Chem; 2004 Jul; 279(28):29787-96. PubMed ID: 15123672
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the muscarinic acetylcholine receptor M₂ subtype with G protein Gα(i/o) isotypes and Gβγ subunits as studied with the maltose-binding protein-M₂-Gα(i/o) fusion proteins expressed in Escherichia coli.
Ichiyama S; Nemoto R; Tanabe H; Haga T
J Biochem; 2014 Nov; 156(5):259-72. PubMed ID: 24881046
[TBL] [Abstract][Full Text] [Related]
20. Allosteric modulation and constitutive activity of fusion proteins between the adenosine A1 receptor and different 351Cys-mutated Gi alpha-subunits.
Klaasse E; de Ligt RA; Roerink SF; Lorenzen A; Milligan G; Leurs R; IJzerman AP
Eur J Pharmacol; 2004 Sep; 499(1-2):91-8. PubMed ID: 15363955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
